MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with H

Hydroxycarbamide

Hydroxycarbamide 1g tablets

Incompatible

Stability notes for Hydroxycarbamide 1g tablets

Cytotoxic and package contains desiccant.

Provenance

This compatibility recommendation is derived from Siklos 1g tablets (Masters Pharmaceuticals Ltd).

Supplier

Siklos 1000mg tablets (Masters Pharmaceuticals Ltd)

Hydroxycarbamide 100mg tablets

Incompatible

Stability notes for Hydroxycarbamide 100mg tablets

Cytotoxic and package contains desiccant.

Provenance

This compatibility recommendation is derived from Siklos 100mg tablets (Masters Pharmaceuticals Ltd).

Supplier

Siklos 100mg tablets (Masters Pharmaceuticals Ltd)

Hydroxycarbamide 300mg capsules

Incompatible

Stability notes for Hydroxycarbamide 300mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Droxia 300mg capsules (Imported (United States))
Hydroxycarbamide 300mg capsules (Special Order)

Hydroxycarbamide 500mg capsules

Incompatible

Stability notes for Hydroxycarbamide 500mg capsules

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers (6) of Hydroxycarbamide 500mg capsules
Hydrea 500mg capsules (Neon Healthcare Ltd)
Hydroxycarbamide 500mg capsules (A A H Pharmaceuticals Ltd)
Hydroxycarbamide 500mg capsules (Alliance Healthcare (Distribution) Ltd)
Hydroxycarbamide 500mg capsules (medac UK)
Hydroxycarbamide 500mg capsules (Medihealth (Northern) Ltd)
Hydroxycarbamide 500mg capsules (Phoenix Healthcare Distribution Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.